Enanta Pharmaceuticals
ENTA
#7512
Rank
HK$3.17 B
Marketcap
HK$110.03
Share price
-1.60%
Change (1 day)
102.19%
Change (1 year)

Earnings for Enanta Pharmaceuticals (ENTA)

Earnings in 2025 (TTM): -HK$0.68 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings are HK$64.8 Million. In 2024 the company made an earning of -HK$0.76 Billion, an increase over its 2023 earnings that were of -HK$1 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enanta Pharmaceuticals from 2012 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$0.68 Billion-11.07%
2024 -HK$0.76 Billion-23.87%
2023 -HK$1 Billion4.39%
2022 -HK$0.95 Billion-4.4%
2021 -HK$1 Billion91.12%
2020 -HK$0.52 Billion-407.13%
2019 HK$0.16 B-78.63%
2018 HK$0.79 B117.97%
2017 HK$0.36 B-574.65%
2016 -HK$76.57 Million-110.83%
2015 HK$0.70 B-4.5%
2014 HK$0.74 B-638.53%
2013 -HK$0.14 Billion-137.98%
2012 HK$0.36 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
AbbVie
ABBV
HK$12.91 B-2,025.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$252.08 B-37,685.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
HK$34.71 B-5,276.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$179.67 B-26,889.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$62.50 B-9,419.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$127.76 B-19,149.33%๐Ÿ‡จ๐Ÿ‡ญ Switzerland